Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Med-Chem Labs is a specialized healthcare company focused on the research and distribution of monolaurin-based nutritional supplements. The company was founded by Dr. Jon J. Kabara, who is credited with discovering the antimicrobial properties of monolaurin in the 1960s. Its flagship product, Lauricidin, is a purified lipid supplement derived from coconut oil, marketed for its ability to support immune health and manage microbial balance. Med-Chem Labs operates primarily in the nutraceutical space, providing products to both healthcare professionals and individual consumers. The company maintains a focus on the biochemical properties of medium-chain fatty acids and their role in human health. Their manufacturing processes emphasize high purity and the exclusion of fillers or additives commonly found in other supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Med-Chem Labs.